Titan Medical Continues to Market Offering of Units
September 24 2019 - 05:00PM
Business Wire
Titan Medical Inc. (“Titan” or the
“Company”) (TSX:TMD) (Nasdaq:TMDI), a medical
device company focused on the design, development and
commercialization of a robotic surgical system for application in
minimally invasive surgery (“MIS”), announced Monday,
September 23, 2019 that it had filed and been receipted for a
preliminary short form prospectus (the “Preliminary
Prospectus”) with securities regulators in the provinces of
Ontario, British Columbia and Alberta. Titan had also filed a
corresponding registration statement on Form F-10 (the
“Registration Statement”) with the United States Securities
and Exchange Commission under the U.S.-Canada Multijurisdictional
Disclosure System.
Further to last night’s press release, the Company has switched
from an overnight marketed offering to a fully marketed offering.
In consultation with its financial advisors, the Company expects to
price the offering no later than September 27, 2019. The
Preliminary Prospectus has been filed on SEDAR and the Registration
Statement has been filed on www.sec.gov.
Pursuant to the terms set forth in the Preliminary Prospectus
and the Registration Statement, it is expected that closing of the
Offering will occur on or about October 8, 2019, or such other date
or dates as the Company and the agent may agree.
About Titan
Titan Medical Inc. is focused on computer-assisted robotic
surgical technologies for application in MIS. The Company is
developing a single-port robotic surgical system comprised of a
surgeon-controlled patient cart that includes a dual-view camera
system with 3D and 2D high-definition vision options and
multi-articulating instruments for performing MIS procedures, and a
surgeon workstation that provides an advanced ergonomic interface
to the patient cart and a 3D endoscopic view inside the patient’s
body. Titan intends to initially pursue gynecologic surgical
indications for use of its single-port robotic surgical system.
For more information, please visit the Company’s website at
www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains “forward-looking statements” within
the meaning of applicable Canadian and U.S. securities laws. Such
statements reflect the current expectations of management of the
Company’s future growth, results of operations, performance and
business prospects and opportunities. Wherever possible, words such
as “may”, “would”, “could”, “will”, “anticipate”, “believe”,
“plan”, “expect”, “intend”, “estimate”, “potential for” and similar
expressions have been used to identify these forward-looking
statements. These statements, including with respect to the closing
date of the Offering, reflect management’s current beliefs with
respect to future events and are based on information currently
available to management. Forward-looking statements involve
significant risks, uncertainties and assumptions. Many factors
could cause the Company’s actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the “Risk Factors” section of the Company’s Annual
Information Form dated March 29, 2019 (which may be viewed at
www.sedar.com). Should one or more of
these risks or uncertainties materialize, or should assumptions
underlying the forward-looking statements prove incorrect, actual
results, performance, or achievements may vary materially from
those expressed or implied by the forward-looking statements
contained in this news release. These factors should be considered
carefully, and prospective investors should not place undue
reliance on the forward-looking statements. Although the
forward-looking statements contained in the news release are based
upon what management currently believes to be reasonable
assumptions, the Company cannot assure prospective investors that
actual results, performance or achievements will be consistent with
these forward-looking statements. Except as required by law, the
Company expressly disclaims any intention or obligation to update
or revise any forward-looking statements whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190924006063/en/
LHA Investor Relations Kim Sutton Golodetz (212) 838-3777
kgolodetz@lhai.com or Bruce Voss (310) 691-7100 bvoss@lhai.com
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Feb 2024 to Mar 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Mar 2023 to Mar 2024